Latest News
July 29, 2021
Bayer Provides Update on Path to Closure of Roundup™ Litigation
July 21, 2021
Not intended for U.S. and UK Media
Bayer’s new symptomatic chronic heart failure treatment Verquvo™ (vericiguat) approved in EU
July 09, 2021
Not intended for U.S. and UK Media
U.S. FDA approves finerenone for the treatment of patients with chronic kidney disease associated with type 2 diabetes